Molina Healthcare (MOH) is receiving various reactions from market analysts. The healthcare company recently announced both Fourth Quarter and Year-End 2024 earnings release and conference call dates, with the actual Q4 earnings set for release on February 5. Their stock has captured significant attention, soaring 18% as premium revenues surge. A crucial factor is MOH's active pursuit of strategic growth, indicating by their recent acquisition of ConnectiCare and a $500M Senior Notes offering. However, despite the positive moves, Truist Financial has shared a somewhat pessimistic forecast for MOH's stock price, lowering the target from $400 to $370, followed by another decrease to $340 by Wells Fargo. Reflecting on the company's performance, Q3 2024 earnings report revealed the firm beat estimates on growing premiums, leading share prices to rally, despite the stock underperforming against other competitors on some days. MOH has successfully secured major dual-eligible contracts in Michigan and Idaho. The surge in implied volatility for MOH stock options indicates that investors might anticipate a significant move for the stock. Despite some bearish views, hedge funds remain bullish on this health insurance stock, and Michael Burry's top 10 stock picks for 2025 included Molina Healthcare, highlighting its potential.
Molina Healthcare MOH News Analytics from Wed, 24 Apr 2024 07:00:00 GMT to Fri, 10 Jan 2025 10:15:11 GMT -
